BioWorld

Jan. 25, 2008

View Archived Issues

MiddleBrook Soars on FDA OK of Once-Daily Strep Antibiotic

MiddleBrook Pharmaceuticals Inc.'s stock skyrocketed Thursday after the FDA approved its once-daily, extended-release amoxicillin tablet, Moxatag. (BioWorld Today) Read More

Gilead Tops Estimates; Earnings Driven by Strong HIV Franchise

Read More

Researchers Make Complete Real, Artificial Chromosome

Read More

Orexigen Prices $77M Follow-On as Obesity Trials Move Ahead

Read More

Other News To Note

Read More

Clinic Roundup

Read More